N-[(1S)-5-Amino-1-cyanopentyl]-2-[(1R)-1-[3-(4-fluorophenyl)-2,5-dioxoimidazolidin-1-yl]ethyl]-1-methyl-1H-1,3-benzodiazole-6-carboxamide

ID: ALA3799329

Chembl Id: CHEMBL3799329

PubChem CID: 127046389

Max Phase: Preclinical

Molecular Formula: C26H28FN7O3

Molecular Weight: 505.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](c1nc2ccc(C(=O)N[C@H](C#N)CCCCN)cc2n1C)N1C(=O)CN(c2ccc(F)cc2)C1=O

Standard InChI:  InChI=1S/C26H28FN7O3/c1-16(34-23(35)15-33(26(34)37)20-9-7-18(27)8-10-20)24-31-21-11-6-17(13-22(21)32(24)2)25(36)30-19(14-29)5-3-4-12-28/h6-11,13,16,19H,3-5,12,15,28H2,1-2H3,(H,30,36)/t16-,19+/m1/s1

Standard InChI Key:  OHXBSHCCWDYDAQ-APWZRJJASA-N

Alternative Forms

  1. Parent:

    ALA3799329

    ---

Associated Targets(Human)

PLAU Tchem Urokinase-type plasminogen activator (2016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLG Tclin Plasminogen (2339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 505.55Molecular Weight (Monoisotopic): 505.2238AlogP: 2.99#Rotatable Bonds: 9
Polar Surface Area: 137.35Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.33CX Basic pKa: 10.20CX LogP: 1.72CX LogD: -0.88
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.34Np Likeness Score: -1.22

References

1. Teno N, Gohda K, Yamashita Y, Otsubo T, Yamaguchi M, Wanaka K, Tsuda Y..  (2016)  Plasmin inhibitors with hydrophobic amino acid-based linker between hydantoin moiety and benzimidazole scaffold enhance inhibitory activity.,  26  (9): [PMID:27009905] [10.1016/j.bmcl.2016.03.047]

Source